Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
HS-10365
i
Other names:
HS-10365, HS10365, HS 10365
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Jiangsu Hansoh Pharma
Drug class:
RET inhibitor
Related drugs:
‹
lenvatinib (90)
selpercatinib (67)
pralsetinib (49)
TAS0953/HM06 (7)
AST-487 (5)
RXDX-105 (5)
EP0031 (4)
FHND5071 (4)
BOS-172738 (3)
HG-6-63-01 (2)
SY-5007 (2)
TY-1091 (2)
XMD15-44 (2)
TPX-0046 (2)
HSL468 (1)
HSL476 (1)
HSN608 (1)
LDD-2633 (1)
PLD-102 (1)
APS03118 (0)
BTG-002814 (0)
HS269 (0)
JNJ-26483327 (0)
LOXO-260 (0)
PLD-101 (0)
SYHA1815 (0)
SKI-G-801 (0)
lenvatinib (90)
selpercatinib (67)
pralsetinib (49)
TAS0953/HM06 (7)
AST-487 (5)
RXDX-105 (5)
EP0031 (4)
FHND5071 (4)
BOS-172738 (3)
HG-6-63-01 (2)
SY-5007 (2)
TY-1091 (2)
XMD15-44 (2)
TPX-0046 (2)
HSL468 (1)
HSL476 (1)
HSN608 (1)
LDD-2633 (1)
PLD-102 (1)
APS03118 (0)
BTG-002814 (0)
HS269 (0)
JNJ-26483327 (0)
LOXO-260 (0)
PLD-101 (0)
SYHA1815 (0)
SKI-G-801 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login